113 related articles for article (PubMed ID: 26077489)
1. Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2015 Aug; 25(16):3213-6. PubMed ID: 26077489
[TBL] [Abstract][Full Text] [Related]
2. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
3. Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem; 2014 Jul; 22(13):3508-14. PubMed ID: 24837157
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic activity of B-fluorinated o-carborane-1,2-bisphenol synthesized via S(N)Ar reaction.
Ohta K; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4728-30. PubMed ID: 22695130
[TBL] [Abstract][Full Text] [Related]
5. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of carborane analogues of tamoxifen.
Beer ML; Lemon J; Valliant JF
J Med Chem; 2010 Nov; 53(22):8012-20. PubMed ID: 21028825
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
[TBL] [Abstract][Full Text] [Related]
8. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
9. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
[TBL] [Abstract][Full Text] [Related]
12. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A
Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
Lv W; Liu J; Skaar TC; O'Neill E; Yu G; Flockhart DA; Cushman M
J Med Chem; 2016 Jan; 59(1):157-70. PubMed ID: 26704594
[TBL] [Abstract][Full Text] [Related]
14. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationship of
Sedlák D; Wilson TA; Tjarks W; Radomska HS; Wang H; Kolla JN; Leśnikowski ZJ; Špičáková A; Ali T; Ishita K; Rakotondraibe LH; Vibhute S; Wang D; Anzenbacher P; Bennett C; Bartunek P; Coss CC
J Med Chem; 2021 Jul; 64(13):9330-9353. PubMed ID: 34181409
[TBL] [Abstract][Full Text] [Related]
16. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
[TBL] [Abstract][Full Text] [Related]
17. The terminal substituents of 7α, 6-hexanyl derivatives of estradiol determine their selective estrogen receptor modulator versus agonist activities.
Hoffman KL; Foster EA; Smith CL
Steroids; 2012 Apr; 77(5):496-503. PubMed ID: 22326682
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor.
Wang Z; Yang Y; Zheng X; Zhang T; Huang W; Yan D; Zhang W; Wang X; Shen Z
J Pharm Pharmacol; 2018 Jul; 70(7):910-918. PubMed ID: 29582419
[TBL] [Abstract][Full Text] [Related]
19. A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone.
Hirata M; Inada M; Matsumoto C; Takita M; Ogawa T; Endo Y; Miyaura C
Biochem Biophys Res Commun; 2009 Mar; 380(2):218-22. PubMed ID: 19159615
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 4,4'-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity.
Guedes G; Amesty Á; Jiménez-Monzón R; Marrero-Alonso J; Díaz M; Fernández-Pérez L; Estévez-Braun A
ChemMedChem; 2015 Aug; 10(8):1403-12. PubMed ID: 26076185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
